Your browser doesn't support javascript.
loading
Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?
Strik, Herwig; Keber, Ursula; Hammoud, Wasim Alhaj; Riera-Knorrenschild, Jorge; Carl, Barbara; Dodel, Richard; Pagenstecher, Axel; Neubauer, Andreas.
Afiliação
  • Strik H; Department of Neurology, Philipps-University, Marburg, Germany. Electronic address: strik@med.uni-marburg.de.
  • Keber U; Department of Neuropathology, Philipps-University, Marburg, Germany.
  • Hammoud WA; Department of Neuroradiology, Philipps-University, Marburg, Germany.
  • Riera-Knorrenschild J; Department of Hematology, Oncology, Immunology, Philipps-University, Marburg, Germany.
  • Carl B; Department of Neurosurgery, Philipps-University, Marburg, Germany.
  • Dodel R; Department of Neurology, Philipps-University, Marburg, Germany.
  • Pagenstecher A; Department of Neuropathology, Philipps-University, Marburg, Germany.
  • Neubauer A; Department of Hematology, Oncology, Immunology, Philipps-University, Marburg, Germany.
Eur J Cancer ; 87: 205-208, 2017 12.
Article em En | MEDLINE | ID: mdl-29050806
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Encefalite / Doença de Hashimoto / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Encefalite / Doença de Hashimoto / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article